Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECLIPSE trial of Mirena versus standard medical treatment for menorrhagia in primary care
2004-001552-37Phase 4Completed
- Sponsor
- University of Birmingham
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of avatrombopag in hypermenorrhea (2 arms), sponsored by University of Birmingham. Primary endpoint: Shaw Menorrhagia Questionnaire. Started Feb 2005; status: completed.
02
Drugs
avatrombopag
03
Conditions
hypermenorrhea
Beyond the preview
Go deeper on 2004-001552-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001552-37.